MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Corticobasal degeneration (CBD)"

  • 2023 International Congress

    Creation of a biobank of patients with Progressive Supranuclear Palsy and Corticobasal Syndrome in Argentina

    B. Couto, G. Mizraji, M. Maza, S. Sargiotto, F. Greloni, I. Paez Paz, E. Avale, T. Falzone (Buenos Aires, Argentina)

    Objective: To generate a longitudinal cohort study and a research-ready biobank of Argentinian patients with corticobasal syndrome (CBS) and progressive supranuclear palsy (PSP). Background: Corticobasal…
  • 2023 International Congress

    Describing the syndrome: a comprehensive analysis of a large cohort of corticobasal syndrome with pathological correlation

    D. Vaughan, M. Theilmann Jensen, D. Lux, L. Wu, Z. Jaunmuktane, T. Revesz, T. Lynch, M. Stamelou, K. Seppi, R. Vandenberghe, T. Warner, K. Bhatia, A. Lees, A. Church, N. Leigh, P. Taba, T. Matsalu, P. Mir, B. Ghosh, M. Picillo, J. Wallin, P. Svenningsson, Y. Compta, J. Rohrer, J. Rowe, H. Morris (London, United Kingdom)

    Objective: To describe the clinical, biomarker, genetic and pathological features of a cohort of patients with corticobasal syndrome (CBS). Background: Corticobasal degeneration (CBD) was first…
  • 2023 International Congress

    Amyloid status differentiates synaptic loss and atrophy in Corticobasal Syndrome.

    N. Holland, G. Savulich, P. Jones, D. Whiteside, D. Street, M. Naessens, M. Malpetti, Y. Hong, T. Fryer, T. Rittman, E. Mulroy, F. Aigbirhio, K. Bhatia, J. O'Brien, J. Rowe (Cambridge, United Kingdom)

    Objective: In this observational/cross-sectional study, we tested whether the degree and extent of in vivo synaptic loss differed in patients with corticobasal syndrome according to…
  • 2023 International Congress

    Brain FDG-PET-MRI for early diagnosis of corticobasal syndrome

    I. Guan, C. Stahl, K. Astudillo, T. Shepherd, S. Frucht, G. Riboldi (New York, USA)

    Objective: To characterize brain fluorodeoxyglucose (FDG) PET-MRI findings in patients with corticobasal syndrome (CBS) and evaluate its utility in early diagnosis of Corticobasal Degeneration (CBD)…
  • 2023 International Congress

    Determinants of care partner burden in atypical parkinsonian syndromes

    M. Ivancic, J. Shurer, M. Schmidt, V. Nesspor, M. Li, Y. Lin, R. Xu, G. Schumock, M. Sklerov, A. Pantelyat (Chapel Hill, USA)

    Objective: To understand the determinants of burden among people caring for individuals diagnosed with progressive supranuclear palsy (PSP), corticobasal syndrome (CBS), or multiple system atrophy…
  • 2023 International Congress

    Early-onset cortico-basal degeneration (CBD) due to a c.2092G>A MAPT mutation

    M. Mata Alvarez-Santullano, L. Lopez-Manzanares, J. Lopez-Lozano, N. Villares, C. Magdaleno, C. Dela Torre (Madrid, Spain)

    Objective: To describe a patient with early-onset atypical parkinsonism that evolved to a classic CBD without dementia, associated to a c.2092G>A MAPT mutation Background: Although…
  • 2023 International Congress

    Autoimmune encephalitis due to antiglycine antibodies presenting as corticobasal syndrome

    S. Secades (Madrid, Spain)

    Objective: To describe a complex case of atypical parkinsonism compatible with corticobasal syndrome (CBS), associated with autoimmune findings in serum and cerebrospinal fluid (CSF) and…
  • 2022 International Congress

    Cannabinoids for painful dystonia in corticobasal syndrome: a report of three patients

    G. Rizzo, P. Avoni, V. Donadio, R. Liguori (Bologna, Italy)

    Objective: We aimed to assess the efficacy of cannabinoids in painful dystonia of corticobasal syndrome (CBS) patients Background: The clinical phenotype of CBS includes limb…
  • 2022 International Congress

    Absence of nigrosome as a finding in a patient with suspected atypical parkinsonism.

    L. Caballero Sánchez, D. Cerdán Santacruz, C. Gómez López, J. Berrío Suaza, P. Gil Armada, M. álvarez Eulate, A. Castrillo Sanz, A. Mendoza Rodriguez, M. Rodríguez Sanz, C. Tabernero García (Segovia, Spain)

    Objective: Reviewing typical neuroimaging features of the substantia nigra.Noting that the absence of nigrosome 1 has also been seen in atypical parkinsonisms. Background: It is…
  • 2022 International Congress

    Clinicopathologic features of corticobasal syndrome associated with corticobasal degeneration, progressive supranuclear palsy, Alzheimer’s disease, and FTLD-TDP

    S. Koga, A. Murakami, D. Dickson (Jacksonville, USA)

    Objective: To compare the clinicopathologic features of corticobasal syndrome (CBS) associated with corticobasal degeneration (CBD), progressive supranuclear palsy (PSP), Alzheimer's disease (AD), and frontotemporal lobar…
  • « Previous Page
  • 1
  • …
  • 4
  • 5
  • 6
  • 7
  • 8
  • …
  • 12
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley